07:29 PM • Dalla Lana School of Public Health • Reporting, epidemic growth, and reproduction numbers for the 2019-nCoV epidemic: understanding control
06:51 PM • Nature • More than 80 clinical trials launch to test coronavirus treatments
06:47 PM • STAT • Once widely criticized, the Wuhan quarantine bought the world time to prepare for Covid-19
04:52 PM • Genetic Engineering & Biotechnology News • Base Editing Promise in Treating a Mouse Model of Progeria
04:48 PM • Nature Biotechnology • Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors
04:42 PM • Nature • Super-precise CRISPR tool enhanced by enzyme engineering
04:33 PM • The Harvard Gazette • A crisper CRISPR
03:52 PM • New England Journal of Medicine (NEJM) • Milk and Health
03:45 PM • Elemental-a Medium publication • Time to Question Everything You Know About Milk
06:06 PM • Genetic Engineering & Biotechnology News • MERS Coronavirus Disease Blocked by Remdesivir in Monkeys
05:55 PM • The Motley Fool • Report: Gilead Struggling to Find Subjects for COVID-19 Drug Trial
05:53 PM • ClinicalTrials.gov • Severe 2019-nCoV Remdesivir RCT
05:51 PM • ClinicalTrials.gov • Severe 2019-nCoV Remdesivir RCT
05:48 PM • BioSpace • Gilead Struggles to Recruit Patients for Coronavirus Drug Trial in China
05:41 PM • Wall Street Journal • Gilead’s Coronavirus Drug Trial Slowed by Lack of Eligible Recruits
04:45 PM • Science • Treg cells—the next frontier of cell therapy
04:42 PM • STAT • Jeffrey Bluestone steps down as Parker Institute president to develop cell therapies for autoimmune diseases
04:39 PM • Endpoints News • Jeffrey Bluestone exits Parker and switches focus back to autoimmune diseases in cell therapy 2.0 launch
04:35 PM • BioSpace • Parker Institute CEO Jeffrey Bluestone Steps Down to Launch Sonoma Biotherapeutics
03:09 PM • The Harvard Gazette • Collaboration generates most complete cancer genome map
02:56 AM • International Cancer Genome Consortium - ICGC • PCAWG - PANCANCER ANALYSIS OF WHOLE GENOMES
02:54 AM • Nature • The era of massive cancer sequencing projects has reached a turning point
02:52 AM • Science • Massive cancer genome study reveals how DNA errors drive tumor growth
09:53 PM • Financial Times • Biogen shares soar after patent victory
09:37 PM • STAT • Biogen wins patent challenge to key multiple sclerosis drug
08:00 PM • Fortune Magazine • China wants to patent Gilead’s promising coronavirus treatment
07:55 PM • TIME (US magazine) • China Applies for Patent for Drug That Could Fight Coronavirus
07:49 PM • ClinicalTrials.gov • Mild/Moderate 2019-nCoV Remdesivir RCT
07:46 PM • The Verge • An experimental antiviral medication might help fight the new coronavirus
07:39 PM • New England Journal of Medicine (NEJM) • First Case of 2019 Novel Coronavirus in the United States
07:37 PM • Seeking Alpha • Testing of Gilead's remdesivir in coronavirus patients to start tomorrow in China
04:27 PM • Fortune Magazine • The Gates Foundation is pledging up to $100 million for the fight against coronavirus
02:54 PM • Bill & Melinda Gates Foundation • Bill & Melinda Gates Foundation Dedicates Additional Funding to the Novel Coronavirus Response
01:42 PM • Wall Street Journal • Merck to Spin Off Slow-Growth Products Into New Company
01:37 PM • Financial Times • GSK outlines plan to split as earnings fall short
01:35 PM • Seeking Alpha • Merck to sharpen focus on key growth drivers via spinout of non-core units
09:14 PM • New England Journal of Medicine (NEJM) • Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
09:13 PM • STAT • High-profile report on asymptomatic spread of coronavirus based on faulty information, health officials say
09:01 PM • Science • Study claiming new coronavirus can be transmitted by people without symptoms was flawed
10:28 PM • CNBC • Trump imposes travel restrictions, mandatory quarantines over coronavirus outbreak
08:09 PM • MarketWatch • Coronavirus update: First U.S. case of person-to-person transmission confirmed, 195 U.S. citizens in isolation and WHO declares a public health emergency
08:03 PM • BBC • Coronavirus declared global health emergency by WHO
08:16 PM • STAT • WHO praises China’s response to coronavirus, will reconvene expert committee to assess global threat
08:13 PM • NBC • Coronavirus risk in U.S. 'remains low' even as federal officials take steps to protect public
08:10 PM • CNBC • US health officials fast-track coronavirus vaccine, hope to start clinical trial in three months
08:08 PM • New York Times • Coronavirus Live Updates: Cases Up Nearly 60%, as Airports Expand Screenings
03:51 PM • University of Queensland • UQ responds to coronavirus pandemic
03:41 PM • Moderna Therapeutics • Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus
03:29 PM • Inovio Pharmaceuticals, Inc. • Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
03:19 PM • CEPI-Coalition for Epidemic PreparednessInnovation • CEPI to fund three programmes to develop vaccines against the novel coronavirus, nCoV-2019